Drug Safety & Pharmacovigilance Content Automation with Quark Publishing Platform (QPP)
Accelerate the production of aggregate reports, PSMFs and regulatory affairs documentation with QPP’s AI-powered, data-driven content automation. Realize time-to-market value faster by delivering accurate, compliant, and globally aligned reports with speed and confidence, all from one scalable platform.
It’s Time for Change
Producing pharmacovigilance and drug safety documentation is often slowed by manual copy-paste across documents, inconsistent safety data at the time of submission, and lengthy medical, regulatory and quality review cycles. Add in the high costs of preparing multilingual submissions for EMA, FDA, and MHRA – plus the ever-present risk of non-compliance with GVP modules, ICH guidelines, and regional requirements – and it’s easy to see why traditional processes struggle to keep pace.
request a call
Why QPP Transforms Regulatory Success
Quark Publishing Platform delivers a comprehensive solution for pharmacovigilance teams, regulatory affairs, and safety officers to communicate quickly, accurately, and compliantly with health authorities through structured, validated content. QPP streamlines the entire lifecycle of drug safety reports and regulatory documentation using AI-powered automation and seamless Microsoft 365 desktop app integration.
Pharmacovigilance Document Automation
Generate PSURs, PBRERs, DSURs and more with structured XML templates and real-time safety data.
Safety & Compliance Reporting
Automate recurring regulatory submissions, aggregate safety reports, and signal detection outputs with fully auditable workflows.
Regulatory Disclosures & Submissions
Ensure compliance with EMA, FDA, MHRA and ICH requirements through controlled content, data integrity guardrails, and embedded approval workflows.
Built for Microsoft Azure, OpenAI & Office 365 Desktop App Integration
Utilize and integrate with the enterprise’s core existing Microsoft technology ecosystem through seamless PowerPoint, Word, and Excel workflows, governed by embedded compliance checks and audit trails.
AI-Powered Accelerator Packs
Reduce onboarding cycles and expansion deployments by 25–30% and cut costs by 50–80% with industry-specific pharmacovigilance accelerators.
request a call
Realize New Productivity, Gain the Edge Over Risk
The measurable efficiency, compliance, and scalability gains across all drug safety and pharmacovigilance reporting processes with QPP drive next-level assurance and confidence in regulatory submissions.
Time-to-submission cut by 50%
50–70% reduction in manual effort for safety writers and reviewers
Audit-ready workflows ensuring inspection readiness
Multilingual scalability for EMA, FDA, and MHRA submission preparation
Build or Buy? The Evidence is Clear
Quark Publishing Platform delivers a complete, reliable solution for pharmacovigilance and regulatory document production, especially when compared with the risks and limitations of building an internal AI-based system, where dedicated employee uncertainty and the futureproofing of ecosystem-wide validation, inspection readiness, and compliance updates pose a significant threat.
| Requirement | QPP Provides | Risk of Building Your Own with AI |
|---|---|---|
| Structured XML content model |  |
 Unstructured output, poor reuse |
| Regulatory compliance (EMA, FDA, MHRA, ICH) | |
High risk of errors & fines |
| Integration with safety data sources (E2B, Argus, ArisG) | |
Complex, high-cost IT builds |
| Multilingual automation | |
Costly, manual translations |
| Audit & inspection readiness | |
Inconsistent, error-prone |
| Microsoft 365 ecosystem | |
Missing or fragmented workflows |
| Maintenance & validation updates | |
Specialist employee dependency, lack of compatibility control |
The CCMS Advantage for Pharmaceutical
Unlike traditional, unstructured content systems, QPP was engineered for accuracy
in regulated industries and was designed to meet the complex data,
reliability, and compliance needs of drug safety and pharmaceutical content.
-
AI-powered automation tailored to aerospace and defense content lifecycles
-
Capability to manage the lifecycle of multiple enterprise-wide document use cases from one centralized platform
-
Structured XML-based CCMS ensuring reuse, accuracy, and audit-readiness
-
Regulatory guardrails built into authoring and publishing workflows
-
True Microsoft Azure, OpenAI and Office 365 desktop ecosystem integration for business-wide adoption
-
Lower total cost of ownership (TCO) and faster deployment than legacy or custom-built solutions
Ideal for Teams in
Request a Call Today
The future of pharmacovigilance reporting is AI-powered, structured, and compliant. Leading life sciences organizations automate drug safety content production, reduce costs, maintain compliance, and deliver regulatory submissions faster across all channels thanks to Quark Publishing Platform.
Request a call today to see how pharmacovigilance, regulatory affairs, and drug safety teams at the world’s leading pharma and biotech companies use QPP to transform their safety and compliance content operations.
request a call
